Tilray Canada Ltd. announced today that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
Nuuvera Inc. (TSXV: NUU) and Aphria Inc. (TSX: APH & US OTC QB: APHQF) announced today that they have executed a previously announced definitive offtake agreement for 60,000 kgs of cannabis production.
Canopy Growth Corporation (TSX:WEED) is pleased to announce that, due to strong demand, it has agreed with a syndicate of underwriters co-led by GMP Securities L.P. and BMO Capital Markets as joint bookrunners, and including Canaccord Genuity Corp., Eight Capital, Beacon Securities Limited, and PI Financial Corp., to increase the size of its previously announced $175,076,000 bought deal offering.
The Canadian recreational cannabis market is one of the most exciting markets in the world. We look at how companies are positioning themselves, and identify one small recreational brand to have a look at.
Choom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to announce it has signed a Letter of Intent to acquire its second, advanced-stage cannabis production licence applicant ("Target") under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
Further to their joint news release dated December 21, 2017, DOJA Cannabis Company Limited (CSE: DOJA) and TS Brandco Holdings Inc. ("Tokyo Smoke") are pleased to announce the signing of a definitive business combination agreement effective as of January 17, 2018, whereby DOJA will acquire all of the issued and outstanding securities of Tokyo Smoke by way of a three-cornered amalgamation.
ABCANN GLOBAL CORPORATION (TSXV: ABCN) is pleased to announce that its wholly-owned subsidiary, ABcann Australia Pty Ltd., has received an import license from the Federal Office of Drug Control in Australia.
CanniMed has determined to postpone the Meeting to allow discussions regarding a possible transaction with Aurora Cannabis Inc. as permitted under the terms of the Arrangement Agreement between CanniMed and Newstike
With unprecedented product demand on the horizon, consumers trends are shifting toward the pursuit of the “cannabis lifestyle,” rich in a wide range of high-quality retail products, accessories and experiences.
Canopy Growth Corporation (TSX: WEED) and the Victorian State Government today announced the signing of a significant Memorandum of Understanding to further develop research and technical capabilities in the production of medical cannabis in Australia.
Anandia Laboratories Inc, a leading cannabis biotechnology and testing company, is pleased to announce that it has closed a private placement financing of common shares of CAD$13.4 million at a post-money valuation of CAD$63 million.